Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,172 | -64,198 | -59,670 | -35,172 | -25,994 |
| Depreciation Amortization | 12,034 | 11,415 | 10,311 | 5,780 | 2,621 |
| Accounts receivable | 174 | -1,428 | -599 | -1,409 | 577 |
| Accounts payable and accrued liabilities | 3,682 | 2,257 | 700 | 1,089 | 4,354 |
| Other Working Capital | -7,945 | 31,894 | 10,102 | 632 | 1,030 |
| Other Operating Activity | -3,029 | 12,344 | 10,364 | 11,090 | 15,910 |
| Operating Cash Flow | $-42,256 | $-7,716 | $-28,792 | $-17,990 | $-1,502 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,827 | -41,930 | 64,551 | 31,476 | -157,739 |
| PPE Investments | -11,720 | -4,776 | -19,766 | -13,471 | -7,709 |
| Purchase Of Investment | N/A | N/A | N/A | -10,835 | N/A |
| Sale Of Investment | N/A | N/A | 10,638 | N/A | N/A |
| Other Investing Activity | 14,372 | 15,115 | -22,794 | 6,434 | -13,879 |
| Investing Cash Flow | $40,479 | $-31,591 | $32,629 | $13,604 | $-179,327 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 34,000 | N/A | 4,000 | N/A | N/A |
| Debt Repayment | -55,179 | N/A | N/A | -3,909 | -1,595 |
| Common Stock Issued | 1,712 | 50,397 | 574 | 718 | 204,330 |
| Financing Cash Flow | $-19,467 | $50,397 | $4,574 | $-3,191 | $202,735 |
| Beginning Cash Position | 35,856 | 24,766 | 16,355 | 23,932 | 2,026 |
| End Cash Position | 14,612 | 35,856 | 24,766 | 16,355 | 23,932 |
| Net Cash Flow | $-21,244 | $11,090 | $8,411 | $-7,577 | $21,906 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,256 | -7,716 | -28,792 | -17,990 | -1,502 |
| Capital Expenditure | -11,811 | -4,824 | -19,766 | -13,471 | -7,709 |
| Free Cash Flow | -54,067 | -12,540 | -48,558 | -31,461 | -9,211 |